FFCP PHASE2:Hg19::chr12:102513998..102514017,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p2@C12orf48 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_C12orf48_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | -5bp_to_ENST00000358383, ENST00000537257_5end |
EntrezGene: | C12orf48 |
HGNC: | 26074 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@C12orf48 |
---|
0.0
2.5
5.0
7.5
10.0
12.5
15.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
migratory neural crest cell | 1.62e-07 | 41 |
Showing 1 to 1 of 1 entries
Ontology term | p-value | n |
---|---|---|
cancer | 8.85e-49 | 235 |
disease of cellular proliferation | 1.82e-48 | 239 |
organ system cancer | 3.25e-28 | 137 |
hematologic cancer | 9.62e-24 | 51 |
immune system cancer | 9.62e-24 | 51 |
cell type cancer | 7.21e-23 | 143 |
carcinoma | 2.83e-19 | 106 |
leukemia | 3.17e-19 | 39 |
myeloid leukemia | 8.88e-15 | 31 |
lymphoma | 5.85e-07 | 10 |
Showing 1 to 10 of 10 entries